These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24266686)

  • 1. Azo reductase- activated colon- targeting prodrugs of aminosalicylates for inflammatory bowel disease: preparation, pharmacokinetic and pharmacodynamic profile.
    Suneela D; Gaurav V; Samuel S
    Inflamm Allergy Drug Targets; 2013 Dec; 12(6):419-32. PubMed ID: 24266686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and development of novel azo prodrugs using various permutations and combinations of 5- and 4-aminosalicylic acids for inflammatory bowel disease: a colon-targeted approach.
    Suneela D; Gaurav V; Himanshu R
    Inflamm Allergy Drug Targets; 2013 Oct; 12(5):328-40. PubMed ID: 24001333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of mitigating effect of colon-specific prodrugs of boswellic acid on 2,4,6-trinitrobenzene sulfonic acid-induced colitis in Wistar rats: Design, kinetics and biological evaluation.
    Sarkate A; Dhaneshwar SS
    World J Gastroenterol; 2017 Feb; 23(7):1147-1162. PubMed ID: 28275295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrugs of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease.
    Dhaneshwar SS; Gairola N; Kandpal M; Vadnerkar G; Bhatt L; Rathi B; Kadam SS
    Eur J Med Chem; 2009 Oct; 44(10):3922-9. PubMed ID: 19442419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Aminosalicylic Acid Azo-Linked to Procainamide Acts as an Anticolitic Mutual Prodrug via Additive Inhibition of Nuclear Factor kappaB.
    Kim W; Nam J; Lee S; Jeong S; Jung Y
    Mol Pharm; 2016 Jun; 13(6):2126-35. PubMed ID: 27112518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macromolecular prodrug of 4-aminosalicylic acid for targeted delivery to inflamed colon.
    Vadnerkar G; Dhaneshwar S
    Curr Drug Discov Technol; 2013 Mar; 10(1):16-24. PubMed ID: 22725691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel azo derivatives as prodrugs of 5-aminosalicylic acid and amino derivatives with potent platelet activating factor antagonist activity.
    Carceller E; Salas J; Merlos M; Giral M; Ferrando R; Escamilla I; Ramis J; García-Rafanell J; Forn J
    J Med Chem; 2001 Aug; 44(18):3001-13. PubMed ID: 11520209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azo-reductase activated budesodine prodrugs for colon targeting.
    Marquez Ruiz JF; Kedziora K; O'Reilly M; Maguire J; Keogh B; Windle H; Kelleher DP; Gilmer JF
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7573-7. PubMed ID: 23122819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colon-specific prodrugs of 4-aminosalicylic acid for inflammatory bowel disease.
    Dhaneshwar SS
    World J Gastroenterol; 2014 Apr; 20(13):3564-71. PubMed ID: 24707139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colon-specific mutual amide prodrugs of 4-aminosalicylic acid for their mitigating effect on experimental colitis in rats.
    Dhaneshwar SS; Chail M; Patil M; Naqvi S; Vadnerkar G
    Eur J Med Chem; 2009 Jan; 44(1):131-42. PubMed ID: 18472188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease.
    Dhaneshwar SS; Kandpal M; Vadnerkar G; Rathi B; Kadam SS
    Eur J Med Chem; 2007 Jun; 42(6):885-90. PubMed ID: 17258353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid with D-phenylalanine for colon specific drug delivery in inflammatory bowel disease.
    Dhaneshwar SS; Gairola N; Kandpal M; Bhatt L; Vadnerkar G; Kadam SS
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1897-902. PubMed ID: 17280832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colon-specific, mutual azo prodrug of 5-aminosalicylic acid with L-tryptophan: synthesis, kinetic studies and evaluation of its mitigating effect in trinitrobenzenesulfonic acid-induced colitis in rats.
    Dhaneshwar SS; Gairola N; Kandpal M; Vadnerkar G; Bhatt L
    Bioorg Med Chem; 2007 Jul; 15(14):4903-9. PubMed ID: 17499512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and ex vivo evaluation of colon-specific azo based prodrugs of anticancer agents.
    Sharma R; Rawal RK; Gaba T; Singla N; Malhotra M; Matharoo S; Bhardwaj TR
    Bioorg Med Chem Lett; 2013 Oct; 23(19):5332-8. PubMed ID: 23968824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation into drug release from colon-specific azoreductase-activated steroid prodrugs using in-vitro models.
    Ruiz JF; Kedziora K; Windle H; Kelleher DP; Gilmer JF
    J Pharm Pharmacol; 2011 Jun; 63(6):806-16. PubMed ID: 21585379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Aminosalicylic Acid Azo-Coupled with a GPR109A Agonist Is a Colon-Targeted Anticolitic Codrug with a Reduced Risk of Skin Toxicity.
    Jeong S; Lee H; Kim S; Ju S; Kim W; Cho H; Kim HY; Heo G; Im E; Yoo JW; Yoon IS; Jung Y
    Mol Pharm; 2020 Jan; 17(1):167-179. PubMed ID: 31743034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: synthesis, in vitro and in vivo assessment.
    El-Kamel AH; Abdel-Aziz AA; Fatani AJ; El-Subbagh HI
    Int J Pharm; 2008 Jun; 358(1-2):248-55. PubMed ID: 18502065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azo chemistry and its potential for colonic delivery.
    Jain A; Gupta Y; Jain SK
    Crit Rev Ther Drug Carrier Syst; 2006; 23(5):349-400. PubMed ID: 17425512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.
    Jung Y; Kim HH; Kim H; Kong H; Choi B; Yang Y; Kim Y
    Eur J Pharm Sci; 2006 May; 28(1-2):26-33. PubMed ID: 16455235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the mitigating effect of colon-specific bioreversible codrugs of mycophenolic acid and aminosugars in an experimental colitis model in Wistar rats.
    Chopade SS; Dhaneshwar SS
    World J Gastroenterol; 2018 Mar; 24(10):1093-1106. PubMed ID: 29563754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.